Biomarkers
Discover all biomarkers in precision medicine
Discover all biomarkers in precision medicine
This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predominantly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties. [provided by RefSeq, Jul 2008]
Chiesi Farmaceutici S.p.A.
Sanofi
Rigshospitalet, Denmark
HIV Vaccine Trials Network
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Fabry Disease
Fabry Disease
Fabry Disease
HIV Infections
Clinical Intelligence Agent
Scientific Literature Agent
5 papers
Cardiovascular disease